相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P. Nusinow et al.
CELL (2020)
Zebrafish patient avatars in cancer biology and precision cancer therapy
Maurizio Fazio et al.
NATURE REVIEWS CANCER (2020)
SORLA regulates endosomal trafficking and oncogenic fitness of HER2
Mika Pietila et al.
NATURE COMMUNICATIONS (2019)
Feedback-Driven Assembly of the Axon Initial Segment
Amelie Freal et al.
NEURON (2019)
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
Yi Ding et al.
NATURE COMMUNICATIONS (2018)
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu et al.
NATURE COMMUNICATIONS (2018)
Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
Sara Rhost et al.
BREAST CANCER RESEARCH (2018)
Zebrafish Embryo Xenograft and Metastasis Assay
Ilkka Paatero et al.
BIO-PROTOCOL (2018)
HER3 signaling and targeted therapy in cancer
Rosalin Mishra et al.
ONCOLOGY REVIEWS (2018)
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Jose Baselga et al.
LANCET ONCOLOGY (2017)
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
David P. Kodack et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Sortilin limits EGFR signaling by promoting its internalization in lung cancer
Hussein Al-Akhrass et al.
NATURE COMMUNICATIONS (2017)
Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells
Yingqiu Zhang et al.
CANCER LETTERS (2016)
SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity
Vanessa Schmidt et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers
David R. Croucher et al.
SCIENCE SIGNALING (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers
David R. Croucher et al.
SCIENCE SIGNALING (2016)
CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
Delphine R. Boulbes et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Emerging Strategies for Treating Brain Metastases from Breast Cancer
David P. Kodack et al.
CANCER CELL (2015)
Retromer in Alzheimer disease, Parkinson disease and other neurological disorders
Scott A. Small et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Neuregulin 1 Type II-ErbB Signaling Promotes Cell Divisions Generating Neurons from Neural Progenitor Cells in the Developing Zebrafish Brain
Tomomi Sato et al.
PLOS ONE (2015)
A nanobuffer reporter library for fine-scale imaging and perturbation of endocytic organelles
Chensu Wang et al.
NATURE COMMUNICATIONS (2015)
Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion
Severine Roselli et al.
ONCOTARGET (2015)
SorLA Complement-type Repeat Domains Protect the Amyloid Precursor Protein against Processing
Arnela Mehmedbasic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells
Jeffrey C. Kang et al.
MABS (2014)
Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
Lin Mei et al.
NEURON (2014)
EGF receptor trafficking: consequences for signaling and cancer
Alejandra Tomas et al.
TRENDS IN CELL BIOLOGY (2014)
The Mysterious Ways of ErbB2/HER2 Trafficking
Vibeke Bertelsen et al.
MEMBRANES (2014)
Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab
E. M. Olson et al.
ANNALS OF ONCOLOGY (2013)
Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
Siyuan Zhang et al.
CANCER RESEARCH (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+breast cancer models
Wenle Xia et al.
BREAST CANCER RESEARCH (2013)
HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation
David B. Vaught et al.
CANCER RESEARCH (2012)
Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing
Anja W. Fjorback et al.
JOURNAL OF NEUROSCIENCE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P. Kodack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis
Deanna M. Navaroli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty et al.
CANCER CELL (2011)
GGA3 Functions as a Switch to Promote Met Receptor Recycling, Essential for Sustained ERK and Cell Migration
Christine Anna Parachoniak et al.
DEVELOPMENTAL CELL (2011)
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
Joan T. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
SORLA/SORL1, a Neuronal Sorting Receptor Implicated in Alzheimer's Disease
Thomas E. Willnow et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin beta 1
Iain R. Hutcheson et al.
BREAST CANCER RESEARCH (2011)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver
Dhara N. Amin et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
Merel Gijsen et al.
PLOS BIOLOGY (2010)
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
Teemu T. Junttila et al.
CANCER CELL (2009)
Pathways and mechanisms of endocytic recycling
Barth D. Grant et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Transparent adult zebrafish as a tool for in vivo transplantation analysis
Richard Mark White et al.
CELL STEM CELL (2008)
VPS10P-domain receptors - regulators of neuronal viability and function
Thomas E. Willnow et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia V. Sergina et al.
NATURE (2007)
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
OM Andersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Endocytic recycling
FR Maxfield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Neuregulins: functions, forms, and signaling strategies
DL Falls
EXPERIMENTAL CELL RESEARCH (2003)
Visualization of interactions among bZip and Rel family proteins in living cells using bimolecular fluorescence complementation
CD Hu et al.
MOLECULAR CELL (2002)
The sorLA cytoplasmic domain interacts with GGA1 and-2 and defines minimum requirements for GGA binding
L Jacobsen et al.
FEBS LETTERS (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)